Pfizer

News

Pharma pledges rapid response to Omicron COVID variant

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to dev

News

Fall in efficacy of Merck's molnupiravir puts Pfizer in driv...

Merck & Co has reported new data with its oral antiviral molnupiravir that suggests it is not as effective against COVID-19 as originally hoped.

News

The critical role of the generics sector during the pandemic

Could safety scupper Ionis, Pfizer's cholesterol drug vupano...

Ionis has reported phase 2b trial data for its Pfizer-partnered antisense drug vupanorsen for cholesterol lowering that showed it met its main efficacy targets, but raised a few safety conc

News

EU authorises first COVID-19 vaccine for 5 to 11 year olds

The European Medicines Agency (EMA) has approved Pfizer and BioNTech's COVID-19 vaccine Comirnaty for children between the ages of five and 11, as EU countries struggle to cope with rising

News

Data hackathon analyses truth behind ‘game-changer’ COVID vaccine

FDA, CDC COVID jab decisions 'will simplify booster messagin...

Three hurdles to allowing booster COVID-19 vaccinations for all adults in the US fell in swift succession on Friday, clearing the way for wider use of the Pfizer/BioNTech and Moderna shots.

Sales & Marketing